![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 39, 27605-27609, September 24, 1999
From the Department of Biochemistry, Institute of Medical Science,
University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan
and the WAVE is a Wiskott-Aldrich syndrome protein
(WASP)-family protein that functions in membrane-ruffling formation
induced by Rac, a Rho family small GTPase. Here we report that WAVE is
a phosphoprotein whose phosphorylation increases in response to various
external stimuli that activate mitogen-activated protein (MAP) kinase
signaling. When Swiss 3T3 cells are stimulated with platelet-derived
growth factor, electrophoretic mobility shift occurs to WAVE, which
reflects hyperphosphorylation. This is perfectly inhibited by the
addition of PD98059, a specific inhibitor of MAP kinase kinase. Indeed,
the ectopic expression of an activated mutant of MAP kinase kinase
induces WAVE mobility shift. When MAP kinase activation is suppressed
by PD98059, the intensity of platelet-derived growth factor-induced
membrane ruffling is greatly reduced. In various cancer cell lines, the
amount of WAVE mobility shift was found to increase significantly,
suggesting the importance of WAVE hyperphosphorylation in the formation
of membrane ruffles and oncogenic transformation.
Wiskott-Aldrich syndrome protein
(WASP)1 has been identified
as the gene product whose mutation causes a human hereditary disease, Wiskott-Aldrich syndrome (1). Ectopic expression studies revealed that
WASP induces the formation of clusters of actin filaments in a manner
dependent on Cdc42, a Rho family small GTPase (2). Soon after the
discovery of WASP, we identified a WASP-related molecule in a search of
Grb2/Ash-binding proteins (3). This novel protein, named neural WASP
(N-WASP), has been shown to function downstream of Cdc42 to induce the
formation of actin microspikes (filopodia) (4). At the
carboxyl-terminal regions of both WASP and N-WASP, there exist
verprolin homology domains that are homologous to one part of
verprolin, a yeast protein that regulates the actin cytoskeleton (5,
6). We demonstrated that the verprolin homology domain in N-WASP
directly binds to actin (7).
To identify a novel WASP-related molecule, we performed a data base
search using the verprolin homology domain amino acid sequence and
identified WAVE (WASP-family verprolin
homologous protein), which was originally isolated in a random cDNA
sequencing project as KIAA0269 (8, 9). The carboxyl-terminal half of WAVE was structurally similar to both WASP and N-WASP, in that WAVE
also possesses the verprolin homology domain and a proline-rich region.
Thus, WAVE was thought to be a new member of the WASP family of proteins.
We then demonstrated that WAVE regulates the actin reorganization that
is essential for the formation of membrane ruffles induced by Rac,
another Rho family member (9). Recently, Machesky and Insall (10)
reported that the carboxyl-terminal fragment of WAVE (they call the
same protein Hs-Scar1) binds to Arp2/3 protein complex and that the
ectopic expression of the fragment suppresses the PDGF-induced
formation of membrane ruffles. Because PDGF-induced membrane-ruffling
formation occurs in a Rac-dependent manner (11), this
result also supports the possibility that WAVE functions downstream of Rac.
Thus, all WASP family proteins have been shown to regulate the
reorganization of the actin cytoskeleton downstream of Cdc42 or Rac,
and Cdc42 has been shown to bind directly to WASP and N-WASP (2, 4,
12). In contrast, we could not detect any direct interaction between
WAVE and Rac by conventional far Western blot assay, and the regulation
mechanism of WAVE remains unclear.
To understand its regulation mechanism, we have examined here whether
WAVE is modified in response to external stimuli that cause membrane
ruffling. As a result, we found that WAVE is hyperphosphorylated by
various signals that activate a MAP kinase signaling cascade.
Cell Culture--
All cells used in this study were cultured in
Dulbecco's modified Eagle's medium (Nissui) supplemented with 10%
fetal calf serum. Serum starvation was done in Dulbecco's modified
Eagle's medium containing 1 mg/ml bovine serum albumin and
insulin/transferrin/sodium selenite supplement (Boehringer Mannheim)
for 24 h.
Stimulants such as PDGF (used at the final concentration of 10 ng/ml),
epidermal growth factor (100 ng/ml), hepatocyte growth factor (100 ng/ml), lysophosphatidic acid (LPA, 200 ng/ml), and bradykinin (100 ng/ml) were purchased from Boehringer Mannheim, Life Technologies,
Inc., Calbiochem, Sigma, and Sigma, respectively. MEK inhibitor,
PD98059, was purchased from Calbiochem.
Alkaline Phosphatase Treatment--
WAVE was immunoprecipitated
from lysates of Swiss 3T3 cells treated with or without PDGF. The
immunoprecipitates, immobilized on protein A-agarose beads (Pierce),
were washed in alkaline phosphatase buffer and then mixed with calf
intestine alkaline phosphatase (Takara Biochem, Inc.). After incubation
for 1 h at 30 °C, the beads were washed and suspended in SDS
sample buffer. As a negative control, calf intestine alkaline
phosphatase pretreated for 30 min at 95 °C was also used.
[32P]Orthophosphate Labeling--
Swiss 3T3 cells
were first serum-starved for 20 h. Culture medium was replaced
with phosphate-free Dulbecco's modified Eagle's medium (Life
Technologies, Inc.) containing 0.5 mCi/ml
[32P]orthophosphate for 4 h. The cell lysates were
subjected to immunoprecipitation with anti-WAVE antibody.
Transient Expression in BHK Cells--
BHK cells were seeded at
a density of 1.6 × 105 in 60-mm dishes and cultured
overnight. 10 µg of expression plasmids were transfected into cells
by the Ca2+ phosphate method as described previously (9).
After incubation for 4 h, cells were washed with fresh medium and
cultured for another 24 h under serum-starved conditions.
Expression Plasmids--
WAVE cDNA was constructed in
pEF-BOS plasmid (Myc-tagged) as described previously (9). The
expression constructs of LA-SDSE (L33A, L37A, S218D, S222E) MEK
(HA-tagged) were prepared as described previously (13). Myc-tagged
Cdc42G12V and Rac1G12V were described previously (9). Myc-tagged
Ha-RasG12V expression plasmids were prepared by inserting the cDNA
fragments encoding Ha-RasG12V, which were amplified by polymerase chain
reaction using the nontagged Ha-RasG12V expression construct as
template (14), into pEF-BOS plasmid.
Antibodies--
The anti-WAVE polyclonal antibody was prepared
as described previously (9). The anti-Myc and the anti-ERK1 and -ERK2
polyclonal antibodies were purchased from Santa Cruz. The anti-HA
monoclonal antibody was from Boehringer Mannheim.
GST Fusion Proteins--
All GST fusion proteins are prepared as
described previously (GST-profilin (15), GST-Grb2/Ash (16), GST-Fyn SH3
(17), and GST-p85 SH3 (18)).
Electrophoretic Mobility Shift of WAVE in Response to Various
Extracellular Stimuli--
It is well known that growth factor
stimulation induces the formation of membrane ruffles. Thus, we first
examined by Western blotting whether WAVE is modified in response to
growth factor stimulation. As shown in Fig.
1A, all growth factors tested
(PDGF to Swiss 3T3 cells, epidermal growth factor to A431 cells, and hepatocyte growth factor to MDCK cells) induced significant mobility shifts in the WAVE signal. All these growth factors bind and activate receptor-type tyrosine kinases. Thus, we next tested the effect of
bradykinin and LPA, which activate G-protein-coupled receptors in Swiss
3T3 cells (19, 20). In these cases, LPA induced a weak but significant
mobility shift in the WAVE signal (Fig. 1B, left). Serum stimulation was also found to induce strong
mobility shift (Fig. 1B, right).
WAVE Is Hyperphosphorylated in Response to PDGF in Swiss 3T3
Cells--
To confirm that these mobility shifts are caused by
phosphorylation, we immunoprecipitated WAVE from Swiss 3T3 cells
treated with or without PDGF and subjected the precipitates to alkaline phosphatase treatment. As shown in Fig.
2A, this treatment hastened the electrophoretic mobility of WAVE. In addition, WAVE from Swiss 3T3
cells not treated with PDGF also migrated a little faster after
alkaline phosphatase treatment. Taken together, these results suggest
that WAVE is constitutively phosphorylated and that PDGF treatment
induces hyperphosphorylation of WAVE.
We next labeled Swiss 3T3 cells with [32P]orthophosphate.
The cell lysates were immunoprecipitated with anti-WAVE antibody and subjected to SDS-polyacrylamide gel electrophoresis. The results indicate that WAVE is indeed a phosphoprotein and becomes
hyperphosphorylated in response to PDGF stimulation (Fig.
2B). The phosphorylation level is up-regulated about 2-fold
by PDGF treatment.
Hyperphosphorylation of WAVE Occurs Downstream of MAP Kinase
Signaling--
We next tried to determine what kinase is involved in
WAVE hyperphosphorylation in response to PDGF treatment. We first
performed Western blot analysis using PY20 and 4G10
anti-phosphotyrosine antibodies to examine whether WAVE is
tyrosine-phosphorylated, but we did not obtain any positive signal
(data not shown).
The mobility shift occurs in response not only to growth factors but
also to LPA and serum, and thus we examined the possible involvement of
the MAP kinase pathway. MAP kinase activation can be estimated very
easily from the mobility shift in Western blotting. As shown in Fig.
3A, the time course of the
activation of MAP kinase correlated well with the mobility shift
(hyperphosphorylation) of WAVE. We also tested the effect of PD98059, a
specific inhibitor of MEK. When PD98059 was added at a concentration of
>50 µM, the activation of MAP kinase was severely
suppressed (Fig. 3B), and the mobility shift of WAVE was
also suppressed, strongly suggesting that the hyperphosphorylation of
WAVE occurs downstream of a MAP kinase signaling cascade.
To further confirm our idea, we ectopically expressed activated mutant
MEK (LA-SDSE mutant) in BHK cells. As shown in Fig. 3C,
expression of active MEK induced the mobility shift of endogenous WAVE.
Under the experimental condition we used, the expression rate of active
MEK was 30-40% of total cells (estimated from immunofluorescence microscopy), and thus most endogenous WAVE proteins seem to become hyperphosphorylated in cells expressing active MEK. The activated mutant of Ras (RasG12V), an activator of MAP kinase pathway, also induced WAVE mobility shift.
Because WAVE functions downstream of Rac, WAVE hyperphosphorylation may
be caused by activation of Rac. Thus, we also expressed an activated
mutant of Rac (Rac1G12V). However, in this case, we did not observe any
significant mobility shift of WAVE. The activated mutant of Cdc42
(Cdc42G12V) also had no effect. These results strongly suggest that the
mobility shift of WAVE is not caused by Rac (or Cdc42) and also imply
that nonclassical MAP kinases such as p38 and c-Jun
NH2-terminal kinase are not involved in the mobility shift
of WAVE, because Cdc42 and Rac have been shown to activate p38 and
c-Jun NH2-terminal kinase pathways in various cell lines
(21, 22).
Suppression of MAP Kinase Cascade Reduces the Intensity of Membrane
Ruffling Induced by PDGF--
Our results described above indicate
that there exists some connection between WAVE and a MAP kinase
signaling cascade. It is well known that PDGF treatment induces both
the activation of MAP kinase signaling and the formation of membrane
ruffles (11, 23), but there have not been any reports on the role of
MAP kinase signaling in membrane-ruffling formation induced by PDGF.
Thus, we tested whether the suppression of MAP kinase signaling had any
effect on the membrane-ruffling formation by using PD98059. Swiss 3T3
cells were stimulated with PDGF in the presence or absence of PD98059
and then were fixed and stained with phalloidin to visualize membrane
ruffling. Before the stimulation with PDGF, there was no significant
morphological difference between cells treated with or without PD98059
(Fig. 4). PDGF treatment induced the
formation of membrane ruffles at 5 min in cells not treated with
PD98059. At 30 min, membrane ruffling still persisted. In contrast, the
PD98059-treated cells also formed some membrane ruffles (indicated by
arrowheads), but they were clearly very weak compared with
cells not treated with PD98059. At 240 min, both cells formed many
stress fibers, probably through the activation of endogenous Rho as
reported previously (20). Although some abnormalities in the
arrangement of stress fibers were seen in cells treated with PD98059,
the amount of actin filaments composing the stress fibers does not seem
to differ significantly from cells not treated with PD98059.
As shown in Fig. 3A, most MAP kinases exist in an inactive
form at 240 min after PDGF treatment. Thus, we also tested the effect
of LPA, which induces both stress fiber formation and MAP kinase
activation, at 10 min. In this case, the treatment with PD98059 was
found to have no significant effect on stress fiber formation (Fig. 4),
suggesting that MAP kinase signaling is specifically involved in the
formation of membrane ruffles.
These results suggest that MAP kinase signaling is not essential for
the formation of membrane ruffles but plays some additive role
specifically in the full induction of membrane-ruffling formation.
Hyperphosphorylation Specifically Inhibits the Binding to
Grb2/Ash--
We next investigated whether WAVE-binding proteins are
changed by PDGF-stimulation. WAVE possesses a proline-rich region that has been shown to bind directly to profilin (9). We examined by
GST-profilin pull-down assay whether the association between WAVE and
profilin is affected by WAVE hyperphosphorylation. However, we did not
see any change in the amount of the precipitated WAVE (Fig.
5A).
The proline-rich region is also known to associate directly with
various SH3 domains. We then examined the association with several SH3
domain-containing proteins such as Grb2/Ash adaptor protein, Fyn
tyrosine kinase, and the p85 subunit of phosphatidylinositol 3-kinase.
As shown in Fig. 5B, we found that only Grb2/Ash bound well
to WAVE. In addition, this binding was strongly inhibited when WAVE was
hyperphosphorylated by PDGF treatment. Taken together, these results
suggest that Grb2/Ash may be a specific binding partner of WAVE, and
the binding may be regulated by PDGF treatment. Because Grb2/Ash has
been shown to be involved in membrane-ruffling formation (24), complex
formation/dissociation between Grb2/Ash and WAVE may be an important
step in inducing ruffling formation properly.
WAVE Mobility Shift in Oncogenically Transformed Cells--
MAP
kinase not only regulates growth and differentiation of normal cells
but also participates in oncogenic transformation. Thus, we
investigated whether there exists any change in the amount or mobility
shift status of WAVE in transformed cells.
We performed Western blot analysis against lysates obtained from
various transformed cells (and their parental nontransformed cells). As
shown in Fig. 6A, there was a
greater tendency for WAVE mobility shift to increase in transformed
cells (v-Ha-Ras-transformed NIH3T3 cells and v-Src-transformed 3Y1
cells) than in parental cells (NIH3T3 cells and 3Y1 cells). In
addition, in HT1080 fibrosarcoma cells that are routinely used for
metastatic invasion studies, most WAVE proteins existed as a
mobility-shifted form. When PD98059 was added to the culture medium,
these mobility shifts were clearly suppressed, which correlated well
with the suppression of MAP kinase activation (Fig. 6B).
These results support our notion described above and strongly suggest
that WAVE may be critical for oncogenic transformation downstream of
MAP kinase.
MAP kinase is a protein kinase that is activated by various
external stimuli and regulates many fundamental processes such as cell
growth and differentiation. The best known function of MAP kinase is to
receive signals from Ras and transmit the signal to the nucleus,
regulating transcription of specific genes that affect the fate of
cells. However, there has been accumulating evidence that MAP kinase
not only transmits the signal to the nucleus but also regulates
cytoplasmic events such as cell motility (25).
We found in this study that suppression of MAP kinase activation
resulted in significant, though not perfect, reduction of membrane
ruffling. WAVE is a strong candidate for a downstream target of MAP
kinase for proper formation of membrane ruffles, because WAVE is
hyperphosphorylated downstream of MAP kinase signaling and has been
shown to be a critical regulator of membrane ruffling downstream of Rac
(9). The WAVE hyperphosphorylation seems to inhibit specifically the
association with Grb2/Ash, although we do not know yet the
physiological relevance of this inhibition. It is quite probable that
Grb2/Ash recruits WAVE to the activated PDGF receptor through the
association between the SH3 domains and the proline-rich region as in
the case of Sos (26, 27), a well known Ras activator. The
hyperphosphorylation that follows by MAP kinase pathway may free WAVE
from Grb2/Ash, and then WAVE may become fully active in inducing the
membrane-ruffling formation.
However, it should be noted that the hyperphosphorylation of WAVE is
not required for membrane-ruffling formation. As described above,
PD98059 treatment could only partially suppress the membrane-ruffling formation. Furthermore, the WAVE hyperphosphorylation is not sufficient for membrane ruffling. Indeed, stimulation of cells with LPA or serum,
both of which induce significant WAVE hyperphosphorylation, does not
induce membrane ruffling. More directly, we confirmed that expression
of active MEK alone did not induce membrane ruffling (data not shown).
Thus, we conclude that the Rac pathway is the main route to induction
of the membrane-ruffling formation and that the MAP kinase pathway
modulates the signaling cascade at some points including WAVE. Now we
do not know how WAVE is regulated by Rac. Because WAVE and Rac can form
protein complexes when co-expressed in COS 7 cells (9), some adaptor
molecule may link between Rac and WAVE. We have performed two-hybrid
screening using various parts of WAVE as bait and identified several
WAVE-specific binding proteins including known and unknown ones (data
not shown), among which we hope the "linking protein" exists.
The important question is what kinase "directly"
hyperphosphorylates WAVE. We performed an in vitro kinase
assay using activated MAP kinase purified from Xenopus
oocyte extracts and found that it indeed phosphorylates the
carboxyl-terminal GST fusion fragment of WAVE (data not shown).
However, the phosphorylation efficiency was very weak (< WAVE mobility shift occurs not only in cells stimulated with growth
factors but also in oncogenically transformed cells. It has been shown
that a MAP kinase cascade is essential for oncogenic transformation by
various oncogenes (29). In addition, LA-SDSE mutant MEK, which is
constitutively active and can remain in the nucleus, can transform
NIH3T3 fibroblasts by itself (19). Rac has also been demonstrated to be
involved in transformation. For example, expression of the dominant
negative form of Rac can suppress transformation by oncogenic Ras (30).
Rac also participates in invasion of carcinoma cells into normal
tissues (31). Thus, taken together, this information suggests that both
MAP kinase and Rac produce critical signals inducing oncogenic
transformation. Considering this, we conclude that WAVE might be a
critical regulator of tumorigenesis by integrating two important
signals for transformation, MAP kinase and Rac.
We thank Kyoko Miki for skillful technical
assistance. We are also grateful to Dr. W. Birchmeier (Max-Delbruck
Center for Molecular Medicine, Berlin, Germany) and Dr. Yoshimi
Takai and Dr. Masato Umikawa (University of Osaka, Osaka, Japan)
for giving us MDCK cells, to Dr. Motoharu Seiki (University of Tokyo,
Tokyo, Japan) for HT1080 cells, to Dr. Mikako Shirouzu and Dr.
Shigeyuki Yokoyama (Institute of Physical and Chemical Research
(RIKEN), Saitama, Japan) for RasG12V cDNA, and to Dr. Tadashi
Yamamoto (University of Tokyo, Tokyo, Japan) for the GST-Fyn SH3 construct.
*
This study was supported in part by a grant-in-aid for
cancer research from the Ministry of Education, Science, and Culture of
Japan and by a grant-in-aid for the Research for the Future Program
from the Japan Society for the Promotion of Science.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Biochemistry,
Inst. of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan. Tel.: 81-3-5449-5510; Fax: 81-3-5449-5417; E-mail: takenawa@ims.u-tokyo.ac.jp.
The abbreviations used are:
WASP, Wiskott-Aldrich syndrome protein;
GST, glutathione
S-transferase;
LPA, lysophosphatidic acid;
MAP, mitogen-activated protein;
MEK, MAP kinase kinase;
PDGF, platelet-derived growth factor;
BHK, baby hamster kidney;
HA, hemagglutinin;
MDCK, Madin-Darby canine kidney.
Phosphorylation of WAVE Downstream of Mitogen-activated Protein
Kinase Signaling*
,
, and
Department of Biophysics, Graduate School of
Science, Kyoto University, Kitashirakawa-oiwake, Kyoto 606-01, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (46K):
[in a new window]
Fig. 1.
Mobility shift of WAVE in response to various
stimuli. A, stimulation with growth factors. Swiss 3T3,
A431, and MDCK cells were stimulated for 5 min with PDGF
(P), epidermal growth factor (E), and hepatocyte
growth factor (H), respectively. The cell lysates were
subjected to Western blotting with anti-WAVE antibody. B,
stimulation of Swiss 3T3 cells with bradykinin, PDGF, LPA, and serum.
I.B., immunoblot.

View larger version (39K):
[in a new window]
Fig. 2.
Hyperphosphorylation of WAVE in response to
PDGF treatment. A, alkaline phosphatase treatment. WAVE
proteins were immunoprecipitated from Swiss 3T3 cells stimulated with
or without PDGF. The immunoprecipitates were treated with alkaline
phosphatase (AP) or heat-inactivated alkaline phosphatase
(C). After treatment, they were subjected to Western
blotting with anti-WAVE antibody. B,
[32P]orthophosphate labeling. Swiss 3T3 cells were
labeled with [32P]orthophosphate for 4 h and then
stimulated with (P) or without (
) PDGF. WAVE proteins were
immunoprecipitated and subjected to SDS-polyacrylamide gel
electrophoresis. The results were examined by Western blotting with
anti-WAVE antibody and autoradiography. The numbers below
the autoradiogram show the intensity of the signals that correlates
with the amount of 32P incorporated into WAVE.
I.B., immunoblot.

View larger version (44K):
[in a new window]
Fig. 3.
Hyperphosphorylation of WAVE downstream of
MAP kinase signaling. A, time course of MAP kinase
activation and WAVE hyperphosphorylation. Swiss 3T3 cells were
serum-starved and then stimulated with PDGF for 10, 30, and 240 min.
The cell lysates were subjected to Western blotting with anti-WAVE,
ERK1, and ERK2 antibodies. B, inhibition of WAVE
hyperphosphorylation by PD98059. Swiss 3T3 cells were first
serum-starved and then pretreated with the indicated concentrations of
PD98059 for 2 h. After the treatment, the cells were stimulated
with PDGF and then harvested. C, WAVE hyperphosphorylation
induced by ectopic expression of active MEK. BHK cells were transfected
with plasmids expressing active Cdc42 (Myc-tagged), active Rac
(Myc-tagged), active Ras (Myc-tagged), or active MEK (HA-tagged). The
cell lysates were subjected to Western blotting with anti-HA, Myc,
ERK2, and WAVE antibodies. I.B., immunoblot.

View larger version (63K):
[in a new window]
Fig. 4.
Requirement of MAP kinase signaling in proper
formation of membrane ruffles. Swiss 3T3 cells were pretreated
with 50 µM PD98059 and then stimulated with PDGF or LPA.
After 10, 30, and 240 min (PDGF) or 10 min (LPA), cells were fixed and
stained with phalloidin to visualize actin filaments. Weak membrane
ruffles formed in PD98059-treated cells are indicated by
arrowheads.

View larger version (58K):
[in a new window]
Fig. 5.
Association with Grb2/Ash is inhibited by
WAVE hyperphosphorylation. A, association with
profilin. GST-profilin was immobilized on beads and then mixed with
lysates of Swiss 3T3 cells treated with (+) or without (
) PDGF. The
bound proteins were analyzed by Western blotting with anti-WAVE
antibody. B, association with Grb2/Ash. Various indicated
GST fusion proteins containing SH3 domains (Grb2/Ash, Fyn, and p85)
were immobilized on beads.

View larger version (34K):
[in a new window]
Fig. 6.
Mobility shift of WAVE in oncogenically
transformed cells. A, mobility shift of WAVE in
oncogenically transformed cells. 3Y1, v-Src-transformed 3Y1
(Src/3Y1), NIH3T3, v-Ha-Ras-transformed NIH3T3
(Ras/NIH3T3), and HT1080 cells were harvested under
serum-starved conditions. The cell lysates were subjected to Western
blotting with anti-WAVE antibody. B, effect of PD98059 on
the WAVE mobility shifts. 50 µM PD98059 was added to the
transformed cells (Src/3Y1, Ras/NIH3T3, and HT1080) for 0, 2, and
24 h. The cell lysates were then subjected to Western blotting
with anti-WAVE antibody. I.B., immunoblot.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
the phosphorylation efficiency of myelin basic protein). More
importantly, the full-length WAVE protein immunoprecipitated from Swiss
3T3 cells not treated with PDGF was not phosphorylated at all (data not
shown). Thus, it is questionable that MAP kinase itself directly
hyperphosphorylates WAVE. Several kinases have been found to be
activated downstream of MAP kinases (28), and we think that such a
kinase(s) phosphorylates WAVE.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Derry, J. M.,
Ochs, H. D.,
and Francke, U.
(1994)
Cell
78,
635-644[CrossRef][Medline]
[Order article via Infotrieve]
2.
Symons, M.,
Derry, J. M.,
Karlak, B.,
Jiang, S.,
Lemahieu, V.,
McCormick, F.,
Francke, U.,
and Abo, A.
(1996)
Cell
84,
723-734[CrossRef][Medline]
[Order article via Infotrieve]
3.
Miki, H.,
Miura, K.,
and Takenawa, T.
(1996)
EMBO J.
15,
5326-5335[Medline]
[Order article via Infotrieve]
4.
Miki, H.,
Sasaki, T.,
Takai, Y.,
and Takenawa, T.
(1998)
Nature
391,
93-96[CrossRef][Medline]
[Order article via Infotrieve]
5.
Donnelly, S. F.,
Pocklington, M. J.,
Pallotta, D.,
and Orr, E.
(1993)
Mol. Microbiol.
10,
585-596[CrossRef][Medline]
[Order article via Infotrieve]
6.
Vaduva, G.,
Martin, N. C.,
and Hopper, A. K.
(1997)
J. Cell Biol.
139,
1821-1833 7.
Miki, H.,
and Takenawa, T.
(1998)
Biochem. Biophys. Res. Commun.
243,
73-78[CrossRef][Medline]
[Order article via Infotrieve]
8.
Nagase, T.,
Seki, N.,
Ishikawa, K.,
Ohira, M.,
Kawarabayasi, Y.,
Ohara, O.,
Tanaka, A.,
Kotani, H.,
Miyajima, N.,
and Nomura, N.
(1996)
DNA Res.
3,
321-329[Abstract]
9.
Miki, H.,
Suetsugu, S.,
and Takenawa, T.
(1998)
EMBO J.
17,
6932-6941[CrossRef][Medline]
[Order article via Infotrieve]
10.
Machesky, L. M.,
and Insall, R. H.
(1998)
Curr. Biol.
8,
1347-1356[CrossRef][Medline]
[Order article via Infotrieve]
11.
Ridley, A. J.,
Paterson, H. F.,
Johnston, C. L.,
Diekmann, D.,
and Hall, A.
(1992)
Cell
70,
401-410[CrossRef][Medline]
[Order article via Infotrieve]
12.
Aspenstrom, P.,
Lindberg, U.,
and Hall, A.
(1996)
Curr. Biol.
6,
70-75[CrossRef][Medline]
[Order article via Infotrieve]
13.
Fukuda, M.,
Gotoh, I.,
Adachi, M.,
Gotoh, Y.,
and Nishida, E.
(1997)
J. Biol. Chem.
272,
32642-32648 14.
Shirouzu, M.,
Morinaka, K.,
Koyama, S.,
Hu, C.-D.,
Hori-Tamura, N.,
Okada, T.,
Kariya, K.,
Kataoka, T.,
Kikuchi, A.,
and Yokoyama, S.
(1998)
J. Biol. Chem.
273,
7737-7742 15.
Suetsugu, S.,
Miki, H.,
and Takenawa, T.
(1998)
EMBO J.
17,
6516-6526[CrossRef][Medline]
[Order article via Infotrieve]
16.
Miki, H.,
Miura, K.,
Matuoka, K.,
Nakata, T.,
Hirokawa, N.,
Orita, S.,
Kaibuchi, K.,
Takai, Y.,
and Takenawa, T.
(1994)
J. Biol. Chem.
269,
5489-5492 17.
Fusaki, N.,
Matsuda, S.,
Nishizumi, H.,
Umemori, H.,
and Yamamoto, T.
(1996)
J. Immunol.
156,
1369-1377[Abstract]
18.
Watanabe, K.,
Fukuchi, T.,
Hosoya, H.,
Shirasawa, T.,
Matuoka, K.,
Miki, H.,
and Takenawa, T.
(1995)
J. Biol. Chem.
270,
13733-13739 19.
Kozma, R.,
Ahmed, S.,
Best, A.,
and Lim, L.
(1995)
Mol. Cell. Biol.
15,
1942-1952[Abstract]
20.
Ridley, A. J.,
and Hall, A.
(1992)
Cell
70,
389-399[CrossRef][Medline]
[Order article via Infotrieve]
21.
Coso, O. A.,
Chiariello, M., Yu, J. C.,
Teramoto, H.,
Crespo, P.,
Xu, N.,
Miki, T.,
and Gutkind, J. S.
(1995)
Cell
81,
1137-1146[CrossRef][Medline]
[Order article via Infotrieve]
22.
Minden, A.,
Lin, A.,
Claret, F. X.,
Abo, A.,
and Karin, M.
(1995)
Cell
81,
1147-1157[CrossRef][Medline]
[Order article via Infotrieve]
23.
Rossomando, A. J.,
Payne, D. M.,
Weber, M. J.,
and Sturgill, T. W.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
6940-6943 24.
Matuoka, K.,
Shibasaki, F.,
Shibata, M.,
and Takenawa, T.
(1993)
EMBO J.
12,
3467-3473[Medline]
[Order article via Infotrieve]
25.
Klemke, R. L.,
Cai, S.,
Giannini, A. L.,
Gallagher, P. J.,
de Lanerolle, P.,
and Cheresh, D. A.
(1997)
J. Cell Biol.
137,
481-492 26.
Rozakis-Adcock, M.,
Fernley, R.,
Wade, J.,
Pawson, T.,
and Bowtell, D.
(1993)
Nature
363,
83-85[CrossRef][Medline]
[Order article via Infotrieve]
27.
Li, N.,
Batzer, A.,
Daly, R.,
Yajnik, V.,
Skolnik, E.,
Chardin, P.,
Bar-Sagi, D.,
Margolis, B.,
and Schlessinger, J.
(1993)
Nature
363,
85-88[CrossRef][Medline]
[Order article via Infotrieve]
28.
Stokoe, D.,
Campbell, D. G.,
Nakielny, S.,
Hidaka, H.,
Leevers, S. J.,
Marshall, C.,
and Cohen, P.
(1992)
EMBO J.
11,
3985-3994[Medline]
[Order article via Infotrieve]
29.
Cowley, S.,
Paterson, H.,
Kemp, P.,
and Marshall, C. J.
(1994)
Cell
77,
841-852[CrossRef][Medline]
[Order article via Infotrieve]
30.
Qiu, R. G.,
Chen, J.,
Kirn, D.,
McCormick, F.,
and Symons, M.
(1995)
Nature
374,
457-459[CrossRef][Medline]
[Order article via Infotrieve]
31.
Shaw, L. M.,
Rabinovitz, I.,
Wang, H. H.,
Toker, A.,
and Mercurio, A. M.
(1997)
Cell
91,
949-960[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. M. Danson, S. M. Pocha, G. B. Bloomberg, and G. O. Cory Phosphorylation of WAVE2 by MAP kinases regulates persistent cell migration and polarity J. Cell Sci., December 1, 2007; 120(23): 4144 - 4154. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sossey-Alaoui, X. Li, and J. K. Cowell c-Abl-mediated Phosphorylation of WAVE3 Is Required for Lamellipodia Formation and Cell Migration J. Biol. Chem., September 7, 2007; 282(36): 26257 - 26265. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Nolz, R. B. Medeiros, J. S. Mitchell, P. Zhu, B. D. Freedman, Y. Shimizu, and D. D. Billadeau WAVE2 Regulates High-Affinity Integrin Binding by Recruiting Vinculin and Talin to the Immunological Synapse Mol. Cell. Biol., September 1, 2007; 27(17): 5986 - 6000. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sossey-Alaoui, A. Safina, X. Li, M. M. Vaughan, D. G. Hicks, A. V. Bakin, and J. K. Cowell Down-Regulation of WAVE3, a Metastasis Promoter Gene, Inhibits Invasion and Metastasis of Breast Cancer Cells Am. J. Pathol., June 1, 2007; 170(6): 2112 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Nakanishi, S. Suetsugu, D. Yamazaki, and T. Takenawa Effect of WAVE2 Phosphorylation on Activation of the Arp2/3 Complex J. Biochem., March 1, 2007; 141(3): 319 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suetsugu, S. Kurisu, T. Oikawa, D. Yamazaki, A. Oda, and T. Takenawa Optimization of WAVE2 complex-induced actin polymerization by membrane-bound IRSp53, PIP3, and Rac J. Cell Biol., May 22, 2006; 173(4): 571 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mitsushima, T. Sezaki, R. Akahane, K. Ueda, S. Suetsugu, T. Takenawa, and N. Kioka Protein kinase A-dependent increase in WAVE2 expression induced by the focal adhesion protein vinexin Genes Cells, March 1, 2006; 11(3): 281 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Abou Kheir, J.-C. Gevrey, H. Yamaguchi, B. Isaac, and D. Cox A WAVE2-Abi1 complex mediates CSF-1-induced F-actin-rich membrane protrusions and migration in macrophages J. Cell Sci., November 15, 2005; 118(22): 5369 - 5379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tcherkezian, E. I. Danek, S. Jenna, I. Triki, and N. Lamarche-Vane Extracellular Signal-Regulated Kinase 1 Interacts with and Phosphorylates CdGAP at an Important Regulatory Site Mol. Cell. Biol., August 1, 2005; 25(15): 6314 - 6329. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Tang, W. Zhang, and S. J. Gunst The Adapter Protein CrkII Regulates Neuronal Wiskott-Aldrich Syndrome Protein, Actin Polymerization, and Tension Development during Contractile Stimulation of Smooth Muscle J. Biol. Chem., June 17, 2005; 280(24): 23380 - 23389. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sossey-Alaoui, X. Li, T. A. Ranalli, and J. K. Cowell WAVE3-mediated Cell Migration and Lamellipodia Formation Are Regulated Downstream of Phosphatidylinositol 3-Kinase J. Biol. Chem., June 10, 2005; 280(23): 21748 - 21755. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bompard and E. Caron Regulation of WASP/WAVE proteins: making a long story short J. Cell Biol., September 27, 2004; 166(7): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ge, Y. Ly, M. Hollenberg, and K. DeFea A {beta}-Arrestin-dependent Scaffold Is Associated with Prolonged MAPK Activation in Pseudopodia during Protease-activated Receptor-2-induced Chemotaxis J. Biol. Chem., September 5, 2003; 278(36): 34418 - 34426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nozumi, H. Nakagawa, H. Miki, T. Takenawa, and S. Miyamoto Differential localization of WAVE isoforms in filopodia and lamellipodia of the neuronal growth cone J. Cell Sci., January 15, 2003; 116(2): 239 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuoka, S. Suetsugu, H. Miki, K. Fukami, T. Endo, and T. Takenawa A Novel Neural Wiskott-Aldrich Syndrome Protein (N-WASP) Binding Protein, WISH, Induces Arp2/3 Complex Activation Independent of Cdc42 J. Cell Biol., January 29, 2001; 152(3): 471 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Takenawa and H Miki WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement J. Cell Sci., January 5, 2001; 114(10): 1801 - 1809. [Abstract] [PDF] |
||||
![]() |
H Nakagawa, H Miki, M Ito, K Ohashi, T Takenawa, and S Miyamoto N-WASP, WAVE and Mena play different roles in the organization of actin cytoskeleton in lamellipodia J. Cell Sci., January 4, 2001; 114(8): 1555 - 1565. [Abstract] [PDF] |
||||
![]() |
M.-F. Carlier, P. Nioche, I. Broutin-L'Hermite, R. Boujemaa, C. Le Clainche, C. Egile, C. Garbay, A. Ducruix, P. Sansonetti, and D. Pantaloni GRB2 Links Signaling to Actin Assembly by Enhancing Interaction of Neural Wiskott-Aldrich Syndrome Protein (N-WASp) with Actin-related Protein (ARP2/3) Complex J. Biol. Chem., July 14, 2000; 275(29): 21946 - 21952. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||